相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challenges
Francesca Tartari et al.
CANCER TREATMENT REVIEWS (2016)
Regression of Chemotherapy-Resistant Polymerase ε (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab
Alessandro D. Santin et al.
CLINICAL CANCER RESEARCH (2016)
Microsatellite Instability as a Biomarker for PD-1 Blockade
Jonathan C. Dudley et al.
CLINICAL CANCER RESEARCH (2016)
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
Kyle C. Strickland et al.
ONCOTARGET (2016)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1
Brooke E. Howitt et al.
JAMA ONCOLOGY (2015)
Improved survival of patients with hypermutation in uterine serous carcinoma
D. Santin Alessandro et al.
GYNECOLOGIC ONCOLOGY REPORTS (2015)
Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy
Anke Vanderstraeten et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Is Microsatellite Instability a Prognostic Marker in Gastric Cancer?: A Systematic Review With Meta-Analysis
Yoon Young Choi et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Prognostic and predictive significance of MSI in stages II/III colon cancer
Zacharenia Saridaki et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma
Siming Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors
Pravin T. P. Kaumaya et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Recombinant vaccinia/fowipox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
Elke Jaeger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Induction of tumour-specific CD8+ cytotoxic T lymphocytes by tumour lysate-pulsed autologous uterine serous papillary cancer
AD Santin et al.
BRITISH JOURNAL OF CANCER (2002)
Development and therapeutic effect of adoptively transferred T cells primed by tumor lysate-pulsed autologous dendritic cells in a patient with metastatic endometrial cancer
AD Santin et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2000)